Posts Tagged: Molly Shoichet
AmacaThera Inc. (co-founded by Prof. Molly Shoichet), a biotechnology company focused on hydrogel-based drug delivery systems, has entered into an exclusive worldwide licensing agreement with Pacira BioSciences, Inc. for the development and commercialization of AMT-143, an investigational long-acting non-opioid anesthetic intended for post-operative pain management.
Four BME core faculty members receive CIHR Project Grant funding Four core faculty members from the University of Toronto’s Institute of Biomedical Engineering (BME) have received funding from the Canadian […]
24 BME graduate students receive Ontario Graduate Scholarships The OGS is a merit-based scholarship that supports graduate students pursuing excellence in academic research across disciplines at publicly funded universities in […]
Four BME trainees recognized with NSERC awards for doctoral and postdoctoral research Four students and postdoctoral fellows from the University of Toronto’s Institute of Biomedical Engineering (BME) have been awarded […]
Five BME faculty members awarded Stem Cell Network funding to advance regenerative medicine research
Five BME Faculty members Awarded Stem Cell Network Funding to Advance Regenerative Medicine Research Five researchers affiliated with the University of Toronto’s Institute of Biomedical Engineering (BME) have received funding […]
Researchers from the Institute of Biomedical Engineering and Chemical Engineering at the University of Toronto have developed a novel method to dramatically extend the duration of glaucoma treatment.
Researchers at the University of Toronto have developed a method for co-delivering therapeutic RNA and potent drugs directly into cells, potentially leading to a more effective treatment of diseases in the future. This research, recently published in Advanced Materials, explores how ionizable drugs can be used to co-formulate small interfering RNA (siRNA) for more effective intracellular delivery.
University Professor Molly Shoichet (ChemE, BME) has been named the inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine. The chair, situated within the Department of Chemical Engineering & Applied Chemistry, was created in November 2023 via a gift from the The P. Austin Family Foundation.
The Institute of Biomedical Engineering (BME) at the University of Toronto is proud to announce that two of its doctoral candidates, David Li and Erica Floreani, have been awarded the prestigious Vanier Canada Graduate Scholarships for the 2024 cycle.
A research team at UHN's Donald K. Johnson Eye Institute in collaboration with the Institute of Biomedical Engineering at the University of Toronto (U of T) has discovered that transplanted retinal cells can share essential materials with host cells in the lab, offering a promising avenue for delivering therapies directly to damaged areas of the eye.
Showing 1 - 10 of 49 results